Rebooting Atrial Fibrillation Ablation in the COVID-19 Pandemic
Brief Title: Rebooting AF Ablation in the COVID-19
Pandemic
Chirag R. Barbhaiya, MD
Lalit Wadhwani, MD
Arun Manmadhan, MD
Ahmed Selim, MD
Robert J. Knotts, MD
Alexander Kushnir, MD, PhD
Michael Spinelli, MD
Lior Jankelson, MD, PhD
Scott Bernstein, MD
David Park, MD, PhD
Douglas Holmes, MD
Anthony Aizer, MD, MSc
Larry A. Chinitz, MD
Leon H. Charney Division of Cardiology. New York University Langone
Health. New York, NY, USA
Relationships to industry are all modest (< $10,000). Dr.
Barbhaiya has received speaking fees/honoraria from Abbott, Inc. and
Zoll, Inc. Dr. Holmes has research support from Abbott. Dr. Aizer has
served as a consultant for Biosense Webster, Inc., received research
support from Abbott Inc., and Sentreheart, Inc., and received fellowship
support from Abbott, Inc., Biotronik, Inc., Boston Scientific, Inc., and
Medtronic, Inc. Dr. Chinitz has received speaking fees / honoraria from
Abbott, Medtronic, Biotronik, Biosense and Fellowship / Research from
Medtronic, Biotronik, and Biosense.
Funding: None
Address for Correspondence:
Dr. Chirag Barbhaiya
Leon H. Charney Division of Cardiology
New York University School of Medicine
550 1st Avenue
New York, NY 10016, USA
Phone: 212-263-5555
Fax: 212-263-8685
E-mail address: chirag.barbhaiya@nyulangone.org
Total word count: 2,844